Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 2.57
2.39 %
$ 275 M
Market Cap
-4.94
P/E
ACRS - REVENUE
Revenue ACRS - Aclaris Therapeutics, Inc.
31.2 M
LAST VALUE
114.99%
2 YEAR CAGR
25.37%
5 YEAR CAGR
0.00%
10 YEAR CAGR